Department of Pediatrics Archive — Page 30 of 54
-
May 27, 2020
Research probes why COVID-19 seems to spare young children
Lung disease experts at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. -
May 21, 2020
State cancer plan has robust input and commitment from Vanderbilt-Ingram Cancer Center
More than a dozen representatives of Vanderbilt University Medical Center helped plan and made a commitment to help carry out the strategy for how Tennessee will prevent cancer and minimize its burden on state residents. -
May 18, 2020
Women in criminal justice system less likely to receive evidence-based treatment for opioid use disorder
Pregnant women involved in the criminal justice system are disproportionately not receiving medications for opioid use disorder, as compared to their peers, according to a Vanderbilt-led study published today in PLOS Medicine. -
May 6, 2020
Unplanned extubations in preterm infants studied
Unplanned extubations (UEs) in adult and pediatric populations have long been associated with poor clinical outcomes and increased costs to health care systems. -
April 30, 2020
PREDICT program expands, opens new Genomics Clinic
A new clinic opening at Vanderbilt University Medical Center will help doctors and patients choose the best drugs for their medical conditions based on the patients’ unique genetic makeup. -
April 29, 2020
Clarksville boy bounces back after COVID-19 infection
After a month of cough, off-and-on fever, not feeling well and isolation, Joseph “Jo Jo” Bostain is back to bouncing on his trampoline, reading Harry Potter books and planting flowers outside his Clarksville home. -
April 29, 2020
Vanderbilt investigators encouraged by early results of placebo-controlled remdesivir trial
A preliminary look at data from hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results.